genOway (NYSE Alternext: ALGEN) is a public company focused on the development of custom genetically-modified (GM) mouse, rat and cellular models. In addition to providing highly advanced technological solutions for transgenesis and model design, genOway offers interactive scientific consulting at every step of the process. genOway considers its interactive consulting an essential part of the design process. genOway utilizes its consultation services to better understand your specific research needs, objectives and goals as well as to help enhance the reliability of your in vivo and in vitro studies.
genOway guarantees its clients exclusive access to key technologies in the field and/or provides its clients with the rights to all technologies and tools proposed and developed.
genOway generated more than 1,500 genetically-modified models in the past 16 years while working with more than 80 pharmaceutical and biotech companies and 265 leading academic institutes. Currently genOway collaborates with 14 of the Top 20 pharmaceutical companies worldwide and 11 universities from the Top 15 US National Ranking.